Blair William & Co. IL Purchases 9,333 Shares of Cardinal Health, Inc. $CAH

Blair William & Co. IL grew its position in Cardinal Health, Inc. (NYSE:CAH) by 80.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,968 shares of the company’s stock after acquiring an additional 9,333 shares during the quarter. Blair William & Co. IL’s holdings in Cardinal Health were worth $3,523,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the company. Columbus Macro LLC lifted its position in shares of Cardinal Health by 1.0% in the 2nd quarter. Columbus Macro LLC now owns 18,013 shares of the company’s stock worth $3,026,000 after acquiring an additional 187 shares during the period. Maryland State Retirement & Pension System lifted its position in shares of Cardinal Health by 3.1% in the 2nd quarter. Maryland State Retirement & Pension System now owns 11,739 shares of the company’s stock worth $1,972,000 after acquiring an additional 354 shares during the period. Optas LLC bought a new stake in shares of Cardinal Health in the 2nd quarter worth approximately $237,000. Ignite Planners LLC bought a new stake in shares of Cardinal Health in the 2nd quarter worth approximately $269,000. Finally, Valmark Advisers Inc. bought a new stake in shares of Cardinal Health in the 2nd quarter worth approximately $282,000. Institutional investors own 87.17% of the company’s stock.

Wall Street Analyst Weigh In

CAH has been the subject of a number of research reports. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. UBS Group reissued a “buy” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Robert W. Baird increased their target price on Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a report on Wednesday, August 13th. Leerink Partners increased their target price on Cardinal Health from $186.00 to $187.00 and gave the stock an “outperform” rating in a report on Monday, October 6th. Finally, Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $166.00.

Cardinal Health Price Performance

CAH stock opened at $154.26 on Tuesday. The business has a fifty day moving average price of $152.00 and a 200 day moving average price of $151.43. Cardinal Health, Inc. has a fifty-two week low of $106.98 and a fifty-two week high of $168.44. The stock has a market capitalization of $36.65 billion, a price-to-earnings ratio of 23.92, a P/E/G ratio of 1.33 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating analysts’ consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $60.16 billion during the quarter, compared to analysts’ expectations of $60.91 billion. During the same period last year, the firm posted $1.84 EPS. The business’s revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 31.63%.

Insider Transactions at Cardinal Health

In other Cardinal Health news, insider Jessica L. Mayer sold 38,078 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the transaction, the insider directly owned 48,457 shares in the company, valued at approximately $7,211,370.74. This trade represents a 44.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Stephen M. Mason sold 41,575 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $6,187,191.50. Following the completion of the transaction, the chief executive officer owned 26,085 shares in the company, valued at $3,881,969.70. The trade was a 61.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 271,676 shares of company stock worth $40,489,525. Corporate insiders own 0.12% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.